Lataa...
Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double‐blind, 8‐week study
A majority of patients with hypertension fail to achieve blood pressure (BP) control despite treatment with commonly prescribed drugs. This randomized, double‐blind phase III trial assessed the superiority of sacubitril/valsartan 200 mg (97/103 mg) to continued olmesartan 20 mg in reducing ambulator...
Tallennettuna:
| Julkaisussa: | J Clin Hypertens (Greenwich) |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8031201/ https://ncbi.nlm.nih.gov/pubmed/29338113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13153 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|